ARTL
NASDAQ · Pharmaceuticals
Artelo Biosciences Inc
$5.34
-0.45 (-7.77%)
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+194.0% upside
Low Target
$11.87
Average Target
$15.70
High Target
$22.80
Current Price
$5.34
Current
$5.34
$5.34
Target
$15.70
$15.70
$11.87
$15.70 avg
$22.80
Scenario Analysis
Bear Case
$11.87
122.3%
Low target
Base Case
$15.70
+194.0%
Avg target
Bull Case
$22.80
+327.0%
High target
Risk/Reward
2.7x
Favorable
Price in Context
52-Week High
$85.80
-93.8% from high
52-Week Low
$3.15
+69.5% from low
Target vs 52W High
$15.70
-81.7% vs high
Peer Consensus — Pharmaceuticals
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| LLY | Strong Buy | 39 | 77% | $1,330.33 | +45.2% |
| JNJ | Buy | 32 | 59% | $299.55 | +24.8% |
| MRK | Buy | 36 | 67% | $159.27 | +33.4% |
| PFE | Hold | 35 | 40% | $33.90 | +24.3% |
| BMY | Hold | 36 | 42% | $174.50 | +196.1% |
| ZTS | Buy | 25 | 64% | $209.87 | +79.8% |
| RPRX | Strong Buy | 16 | 88% | $36.26 | -22.9% |
| VTRS | Buy | 18 | 67% | $122.82 | +809.8% |